Drug-based approaches to modulate mitochondrial condition in the case of atherosclerosis: focus on correction of mitochondria dysfunction

Abstract

Mutations in mitochondrial DNA can cause mitochondrial diseases. This review focuses on the main functions of mitochondria and the effect of mutations in mtDNA on the processes of mitophagy, mitodynamics and mitochondrial biogenesis. The main mitochondrial diseases associated with specific mutations in mtDNA are reviewed, with an emphasis on atherosclerosis. It is assumed that mtDNA mutations can provoke pathological changes in the intima of the human aorta and activate a specific immune response, ultimately leading to the development of atherosclerosis. Special attention is paid to the methods of targeted therapy of mitochondrial diseases with the use of antioxidants, mitodynamics modifiers, and phototheranostics.

Keywords

Atherosclerosis / mitochondrial mutations / antioxidants / mitodynamics modifiers / phototheranostics

References

[1] GrayMW.Mitochondrial evolution.Cold Spring Harb Perspect Biol2012;4:a011403 PMCID:PMC3428767

[2] MishraP.Metabolic regulation of mitochondrial dynamics.J Cell Biol2016;212:379-87 PMCID:PMC4754720

[3] AndersonS,BarrellBG.Sequence and organization of the human mitochondrial genome.Nature1981;290:457-65

[4] BarshadG,CohenT.Mitochondrial DNA transcription and its regulation: an evolutionary perspective.Trends Genet2018;34:682-92

[5] SbisàE,ReyesA,SacconeC.Mammalian mitochondrial D-loop region structural analysis: identification of new conserved sequences and their functional and evolutionary implications.Gene1997;205:125-40

[6] BerardoA,ToscanoA.Cardiological manifestations of mitochondrial respiratory chain disorders.Acta Myol2011;30:9-15 PMCID:PMC3185833

[7] WallaceDC.Mitochondrial genetic medicine.Nat Genet2018;50:1642-9

[8] FukuiH.Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons.Hum Mol Genet2009;18:1028-36 PMCID:PMC2722231

[9] NesbittV,TurnbullDM.The UK MRC mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A>G mutation-implications for diagnosis and management.J Neurol Neurosurg Psychiatry2013;84:936-8

[10] LakeNJ,RahmanS.Leigh syndrome: one disorder, more than 75 monogenic causes.Ann Neurol2016;79:190-203

[11] OrekhovAN,SukhorukovVN,NikiforovNG.Do mitochondrial DNA mutations play a key role in the chronification of sterile inflammation?.Curr Pharm Des2021;27:276-92

[12] SobeninIA,PostnovAY,BobryshevYV.Association of mitochondrial genetic variation with carotid atherosclerosis.PLoS One2013;8:e68070 PMCID:PMC3706616

[13] GencerS,vander Vorst EPC,WeberC.Inflammatory chemokines in atherosclerosis.Cells2021;10:226 PMCID:PMC7911854

[14] YouleRJ.Mechanisms of mitophagy.Nat Rev Mol Cell Biol2011;12:9-14 PMCID:PMC4780047

[15] ZorovDB,SollottSJ.Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.Physiol Rev2014;94:909-50 PMCID:PMC4101632

[16] van der Bliek AM, Sedensky MM, Morgan PG. Cell biology of the mitochondrion.Genetics2017;207:843-71 PMCID:PMC5676242

[17] BrandMD,PerevoshchikovaIV.The role of mitochondrial function and cellular bioenergetics in ageing and disease.Br J Dermatol2013;169:1-8 PMCID:PMC4321783

[18] LinDS,HoCS.Oxidative insults and mitochondrial DNA mutation promote enhanced autophagy and mitophagy compromising cell viability in pluripotent cell model of mitochondrial disease.Cells2019;8:65 PMCID:PMC6356288

[19] SalnikovaD,GrechkoA.Mitochondrial dysfunction in vascular wall cells and its role in atherosclerosis.Int J Mol Sci2021;22:8990 PMCID:PMC8396504

[20] HayatMA. Autophagy: cancer, other pathologies, inflammation, immunity, infection, and aging. 2015. Available from: https://linkinghub.elsevier.com/retrieve/pii/C2013018837X [Last accessed on 5 Dec 2023].

[21] Soucy-FaulknerA,FinkK.Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression.PLoS Pathog2010;6:e1000930 PMCID:PMC2880583

[22] MarchioP,VilaJM,VictorVM.Targeting early atherosclerosis: a focus on oxidative stress and inflammation.Oxid Med Cell Longev2019;2019:8563845 PMCID:PMC6636482

[23] SentmanML,WesterlundS.Extracellular superoxide dismutase deficiency and atherosclerosis in mice.Arterioscler Thromb Vasc Biol2001;21:1477-82

[24] SchrepferE.Mitofusins, from mitochondria to metabolism.Molecular Cell2016;61:683-94

[25] TwigG,MolinaAJA.Fission and selective fusion govern mitochondrial segregation and elimination by autophagy.EMBO J2008;27:433-46 PMCID:PMC2234339

[26] WestermannB.Bioenergetic role of mitochondrial fusion and fission.Biochim Biophys Acta2012;1817:1833-8

[27] PalikarasK,TavernarakisN.Mechanisms of mitophagy in cellular homeostasis, physiology and pathology.Nat Cell Biol2018;20:1013-22

[28] JinSM,WangC,NarendraDP.Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL.J Cell Biol2010;191:933-42 PMCID:PMC2995166

[29] YamanoK.PINK1 is degraded through the N-end rule pathway.Autophagy2013;9:1758-69 PMCID:PMC4028335

[30] KaneLA,FogelAI.PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.J Cell Biol2014;205:143-53 PMCID:PMC4003245

[31] VillaE,RicciJE.No Parkin zone: mitophagy without parkin.Trends Cell Biol2018;28:882-95

[32] LiuL,ChenQ.Receptor-mediated mitophagy in yeast and mammalian systems.Cell Res2014;24:787-95 PMCID:PMC4085769

[33] SentelleRD,JiangW.Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy.Nat Chem Biol2012;8:831-8 PMCID:PMC3689583

[34] OhtakeF,SaekiY.K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains.Proc Natl Acad Sci USA2018;115:E1401-8 PMCID:PMC5816176

[35] HariharanN,NakaeJ,DepinhoRA.Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes.Circ Res2010;107:1470-82 PMCID:PMC3011986

[36] KimJ.Regulation of the autophagy initiating kinase ULK1 by nutrients: roles of mTORC1 and AMPK.Cell Cycle2011;10:1337-8

[37] NwadikeC,GallagherLE,ChanEYW.AMPK inhibits ULK1-dependent autophagosome formation and lysosomal acidification via distinct mechanisms.Mol Cell Biol2018;38:e00023-18 PMCID:PMC5954193

[38] ScarpullaRC.Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network.BBA Mol Cell Res2011;1813:1269-78 PMCID:PMC3035754

[39] GleyzerN,ScarpullaRC.Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators.Mol Cell Biol2005;25:1354-66 PMCID:PMC548005

[40] KongX,XueY.Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis.PLoS One2010;5:e11707 PMCID:PMC2908542

[41] KerstenS.Integrated physiology and systems biology of PPARα.Mol Metab2014;3:354-71 PMCID:PMC4060217

[42] QuanY,TianG,LiuX.Mitochondrial ROS-modulated mtDNA: a potential target for cardiac aging.Oxid Med Cell Longev2020;2020:9423593 PMCID:PMC7139858

[43] NakahiraK,RathinamVAK.Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.Nat Immunol2011;12:222-30 PMCID:PMC3079381

[44] WeiMC,ChengEHY.Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.Science2001;292:727-30 PMCID:PMC3049805

[45] ChenL,WangY.Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway.Am J Transl Res2020;12:428-46 PMCID:PMC7061836

[46] OslowskiCM,O’sullivan-murphyB.Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome.Cell Metab2012;16:265-73 PMCID:PMC3418541

[47] SakuraiA,HimenoS.Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.J Cell Physiol2005;203:529-37

[48] SwansonKV,TingJPY.The NLRP3 inflammasome: molecular activation and regulation to therapeutics.Nat Rev Immunol2019;19:477-89 PMCID:PMC7807242

[49] WuN,ShaywitzA.AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.Mol Cell2013;49:1167-75 PMCID:PMC3615143

[50] HanX,FangQ.Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy.Redox Biol2021;44:102010 PMCID:PMC8182123

[51] HoltIJ,Morgan-HughesJA.Deletions of muscle mitochondrial DNA.Lancet1988;1:1462

[52] NgYS,GormanGS.Mitochondrial disease in adults: recent advances and future promise.Lancet Neurol2021;20:573-84

[53] BrandonM,WallaceDC.Mitochondrial mutations in cancer.Oncogene2006;25:4647-62

[54] MancusoM,FilostoM.MERRF syndrome without ragged-red fibers: the need for molecular diagnosis.Biochem Biophys Res Commun2007;354:1058-60

[55] ZevianiM,DiMauroS.Deletions of mitochondrial DNA in Kearns-Sayre syndrome.Neurology1988;38:1339-46

[56] WallaceDC.Mitochondrial defects in neurodegenerative disease.Ment Retard Dev Disabil Res Rev2001;7:158-66

[57] RossignolR,RocherC,MazatJP.Mitochondrial threshold effects.Biochem J2003;370:751-62 PMCID:PMC1223225

[58] SchmiedelJ,SchäferJ.Mitochondrial cytopathies.J Neurol2003;250:267-77

[59] JohnsDR,ParkRD.An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy.Biochem Biophys Res Commun1992;187:1551-7

[60] MarieSKN,Marques-diasMJ,KokF.The prevalence of mitochondrial DNA mutations in Leigh syndrome in a Brazilian series.Med Express2014;1:239-42Available from: https://www.scielo.br/j/medical/a/zRN3Vnp8Vj6DDKQBnSHyZkR/?lang=en [Last accessed on 7 Dec 2023]

[61] de Vries DD, van Engelen BGM, Gabreëls FJM, Ruitenbeek W, van Oost BA. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh’s syndrome.Ann Neurol1993;34:410-2

[62] LengY,FangX.The mitochondrial DNA 10197 G >A mutation causes MELAS/leigh overlap syndrome presenting with acute auditory agnosia.Mitochondrial DNA2015;26:208-12

[63] ShanskeS,LuJ.The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases.Arch Neurol2008;65:368-72

[64] LorenzoniPJ,KayCSK,WerneckLC.When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?.Arq Neuro-Psiquiatr2014;72:803-11

[65] WangYX.Progress in diagnosing mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.Chin Med J2015;128:1820-5 PMCID:PMC4733719

[66] GilBorlado MC,GonzalezHoyuela M.Impact of the mitochondrial genetic background in complex III deficiency.PLoS One2010;5:e12801 PMCID:PMC2941448

[67] YanN,GuoB.A novel mitochondrial tRNA(Val) T1658C mutation identified in a CPEO family.Mol Vis2010;16:1736-42 PMCID:PMC2927373

[68] ElsonJL,BlakelyEL,TaylorRW.Pathogenic mitochondrial tRNA mutations-which mutations are inherited and why?.Hum Mutat2009;30:E984-92

[69] ZapicoSC.mtDNA mutations and their role in aging, diseases and forensic sciences.Aging Dis2013;4:364-80 PMCID:PMC3843653

[70] MaassenJA,tHart LM.Maternally inherited diabetes and deafness: a diabetic subtype associated with a mutation in mitochondrial DNA.Horm Metab Res1997;29:50-5

[71] ChenFL,SongXY.A novel mitochondrial DNA missense mutation at G3421A in a family with maternally inherited diabetes and deafness.Mutat Res2006;602:26-33

[72] ZhelankinAV.[Association of the mutations in the human mitochondrial genome with chronic non-inflammatory diseases: type 2 diabetes, hypertension and different types of cardiomyopathy].Patol Fiziol Eksp Ter2012;3:123-8

[73] WortmannSB,vanden Heuvel L.Mitochondrial DNA m.3242G>A mutation, an under diagnosed cause of hypertrophic cardiomyopathy and renal tubular dysfunction?.Eur J Med Genet2012;55:552-6

[74] MaL,ChenJ.Mitochondrial gene variation in type 2 diabetes mellitus: detection of a novel mutation associated with maternally inherited diabetes in a Chinese family.Chin Med J2000;113:111-6

[75] SchaeferAM,TurnbullDM.Endocrine disorders in mitochondrial disease.Mol Cell Endocrinol2013;379:2-11 PMCID:PMC3820028

[76] DabravolskiSA,BaigMS.The role of mitochondrial mutations and chronic inflammation in diabetes.Int J Mol Sci2021;22:6733 PMCID:PMC8268113

[77] BenderA,MorrisCM.High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.Nat Genet2006;38:515-7

[78] KaukonenJ,TirantiV.Role of adenine nucleotide translocator 1 in mtDNA maintenance.Science2000;289:782-5

[79] SpelbrinkJN,TirantiV.Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria.Nat Genet2001;28:223-31

[80] Van Goethem G, Dermaut B, Löfgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.Nat Genet2001;28:211-2

[81] PetrosJA,Ruiz-PesiniE.mtDNA mutations increase tumorigenicity in prostate cancer.Proc Natl Acad Sci USA2005;102:719-24 PMCID:PMC545582

[82] DabravolskiSA,OrekhovAN.The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression.Biomed Pharmacother2021;142:112041

[83] DabravolskiSA,BaigMS,OrekhovAN.Mitochondrial lipid homeostasis at the crossroads of liver and heart diseases.Int J Mol Sci2021;22:6949 PMCID:PMC8268967

[84] DingY,FanF,XuP.The role of mitochondrial DNA mutations in hearing loss.Biochem Genet2013;51:588-602

[85] MalekmohammadK,Rafieian-KopaeiM.Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms.Front Cardiovasc Med2021;8:707529 PMCID:PMC8450356

[86] BezsonovEE,OrekhovAN.Immunopathology of atherosclerosis and related diseases: focus on molecular biology.Int J Mol Sci2021;22:4080 PMCID:PMC8071216

[87] MushenkovaNV,OrekhovaVA,StarodubovaAV.Recognition of oxidized lipids by macrophages and its role in atherosclerosis development.Biomedicines2021;9:915 PMCID:PMC8389651

[88] MezentsevA,KashirskikhD,EidAH.Proatherogenic sialidases and desialylated lipoproteins: 35 years of research and current state from bench to bedside.Biomedicines2021;9:600 PMCID:PMC8228531

[89] BezsonovE,VinokurovA.Effects of native and modified low-density lipoproteins on mitophagy.Atherosclerosis2023;375:98-100

[90] TianF,LiuXW,ZhangZY.Age-dependent accumulation of mitochondrial DNA deletions in the aortic root of atherosclerosis-prone apolipoprotein E-knockout mice.Arch Gerontol Geriatr2016;63:72-7

[91] UmbriaM,AlujaMP.The role of control region mitochondrial DNA mutations in cardiovascular disease: stroke and myocardial infarction.Sci Rep2020;10:2766 PMCID:PMC7026394

[92] MitrofanovKY,ShiganovaGM.Analysis of mitochondrial DNA heteroplasmic mutations A1555G, C3256T, T3336C, С5178А, G12315A, G13513A, G14459A, G14846А and G15059A in CHD patients with the history of myocardial infarction.Exp Mol Pathol2016;100:87-91

[93] SawabeM,ChidaK.Mitochondrial haplogroups A and M7a confer a genetic risk for coronary atherosclerosis in the Japanese elderly: an autopsy study of 1,536 patients.J Atheroscler Thromb2011;18:166-75

[94] KirichenkoTV,KhasanovaZB.Data on association of mitochondrial heteroplasmy and cardiovascular risk factors: comparison of samples from Russian and Mexican populations.Data Brief2018;18:16-21 PMCID:PMC5995799

[95] SazonovaMA,BarinovaVA.Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta.Biomed Res Int2015;2015:825468 PMCID:PMC4365331

[96] AsharFN,LongchampsRJ.Association of mitochondrial DNA copy number with cardiovascular disease.JAMA Cardiol2017;2:1247-55 PMCID:PMC5710361

[97] LiuLP,NingMA.Association between peripheral blood cells mitochondrial DNA content and severity of coronary heart disease.Atherosclerosis2017;261:105-10

[98] HuH,XuX,ChenX.The alterations of mitochondrial DNA in coronary heart disease.Exp Mol Pathol2020;114:104412

[99] WillcoxJAL,MortonSU.Neither cardiac mitochondrial DNA variation nor copy number contribute to congenital heart disease risk.Am J Hum Genet2022;109:961-6 PMCID:PMC9118105

[100] PoznyakAV,PopkovaTV,OrekhovAN.Immunity in atherosclerosis: focusing on T and B cells.Int J Mol Sci2021;22:8379 PMCID:PMC8395064

[101] VakhtangadzeT,SinghU,BezsonovE.Gender differences in atherosclerotic vascular disease: from lipids to clinical outcomes.Front Cardiovasc Med2021;8:707889 PMCID:PMC8273377

[102] KuroOM.Phosphate as a pathogen of arteriosclerosis and aging.J Atheroscler Thromb2021;28:203-13 PMCID:PMC8048948

[103] EllamTJ.Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease.Atherosclerosis2012;220:310-8

[104] McCarthyL.The emerging landscape of eukaryotic polyphosphatases.FEBS Lett2023;597:1447-61

[105] KalebinaTS,ArbatskiiNP,GorkovskiiAA.The role of high-molecular-weight polyphosphates in activation of glucan transferase Bgl2p from Saccharomyces cerevisiae cell wall.Dokl Biochem Biophys2008;420:142-5

[106] MorrisseyJH,SmithSA.Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation.Blood2012;119:5972-9 PMCID:PMC3383012

[107] PengW,XiaY.Mitochondrial dysfunction in atherosclerosis.DNA Cell Biol2019;38:597-606

[108] DurhamAL,ScatenaM,ShanahanCM.Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness.Cardiovasc Res2018;114:590-600 PMCID:PMC5852633

[109] SazonovaMA,BarinovaVA.Association of mitochondrial mutations with the age of patients having atherosclerotic lesions.Exp Mol Pathol2015;99:717-9

[110] CalabreseC,GriffinH.Heteroplasmic mitochondrial DNA variants in cardiovascular diseases.PLoS Genet2022;18:e1010068 PMCID:PMC9007378

[111] HeftiE.Mitochondrial DNA heteroplasmy in cardiac tissue from individuals with and without coronary artery disease.Mitochondrial DNA A DNA Mapp Seq Anal2018;29:587-93 PMCID:PMC5694712

[112] RöckenC,BühlingF.Prevalence and pathology of amyloid in atherosclerotic arteries.Arterioscler Thromb Vasc Biol2006;26:676-7

[113] WicknerRB,SonM,DeWildeM.Anti-prion systems in yeast and inositol polyphosphates.Biochemistry2018;57:1285-92 PMCID:PMC7321833

[114] BezsonovEE,GalzitskayaOV.Amyloidogenic peptides of yeast cell wall glucantransferase Bgl2p as a model for the investigation of its pH-dependent fibril formation.Prion2013;7:175-84 PMCID:PMC3609127

[115] WicknerRB,BatemanDA.Yeast prions: proteins templating conformation and an anti-prion system.PLoS Pathog2015;11:e1004584 PMCID:PMC4412292

[116] ObasV.The aging heart.Clin Sci2018;132:1367-82

[117] WuNN,RenJ.Mitophagy, mitochondrial dynamics, and homeostasis in cardiovascular aging.Oxid Med Cell Longev2019;2019:1-15 PMCID:PMC6875274

[118] WangJC.Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence.Circ Res2012;111:245-59

[119] MartinetW,DeMeyer GRY,KockxMM.Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques.Circulation2002;106:927-32

[120] BreitschopfK,DimmelerS.Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism.FEBS Lett2001;493:21-5

[121] SahinE,LiesaM.Telomere dysfunction induces metabolic and mitochondrial compromise.Nature2011;470:359-65 PMCID:PMC3741661

[122] GusevE.Atherosclerosis and inflammation: insights from the theory of general pathological processes.Int J Mol Sci2023;24:7910 PMCID:PMC10178362

[123] KoushkiK,KeshavarzM,SathyapalanT.Gold nanoparticles: multifaceted roles in the management of autoimmune disorders.Biomolecules2021;11:1289 PMCID:PMC8470500

[124] OrekhovAN,SobeninIA,IvanovaEA.Mitochondrion as a selective target for the treatment of atherosclerosis: role of mitochondrial DNA mutations and defective mitophagy in the pathogenesis of atherosclerosis and chronic inflammation.Curr Neuropharmacol2020;18:1064-75 PMCID:PMC7709151

[125] SobeninIA,PostnovAY,OrekhovAN.Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta.Clin Dev Immunol2012;2012:832464 PMCID:PMC3446814

[126] ZhuninaOA,GrechkoAV.The role of mitochondrial dysfunction in vascular disease, tumorigenesis, and diabetes.Front Mol Biosci2021;8:671908 PMCID:PMC8138126

[127] VolobuevaA,YetSF,OrekhovA.Changes in mitochondrial genome associated with predisposition to atherosclerosis and related disease.Biomolecules2019;9:377 PMCID:PMC6723661

[128] YuE,MercerJR.Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.Circulation2013;128:702-12

[129] SobeninIA,KhasanovaZB.Heteroplasmic variants of mitochondrial DNA in Atherosclerotic lesions of human aortic intima.Biomolecules2019;9:455 PMCID:PMC6770808

[130] FreigangS,MillerE,PalinskiW.Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.Arterioscler Thromb Vasc Biol1998;18:1972-82

[131] ZhouR,MenuP.A role for mitochondria in NLRP3 inflammasome activation.Nature2011;469:221-5

[132] TallAR.Inflammasomes and atherosclerosis: a mixed picture.Circ Res2023;132:1505-20 PMCID:PMC10213995

[133] BultéD,RomanoA.Inflammasomes: mechanisms of action and involvement in human diseases.Cells2023;12:1766 PMCID:PMC10340308

[134] Shahbaz S, Koushki K, Ayati SH, Bland AR, Bezsonov EE, Sahebkar A. Inflammasomes and colorectal cancer.Cells2021;10:2172 PMCID:PMC8467678

[135] CoppiL,MitroN,DeFabiani E.PGC1s and beyond: disentangling the complex regulation of mitochondrial and cellular metabolism.Int J Mol Sci2021;22:6913 PMCID:PMC8268830

[136] SazonovaMA,RyzhkovaAI.Creation of cybrid cultures containing mtDNA mutations m.12315G>A and m.1555G>A, associated with atherosclerosis.Biomolecules2019;9:499 PMCID:PMC6770504

[137] WangX,FrankJA,LuoJ.Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells.Toxicol Appl Pharmacol2017;320:26-31 PMCID:PMC5759049

[138] ColomboB,ComiG.Riboflavin and migraine: the bridge over troubled mitochondria.Neurol Sci2014;35 Suppl 1:141-4

[139] SongSB,KangHT.Modulation of mitochondrial membrane potential and ROS generation by nicotinamide in a manner independent of SIRT1 and mitophagy.Mol Cells2017;40:503-14 PMCID:PMC5547220

[140] KangHT.Nicotinamide enhances mitochondria quality through autophagy activation in human cells.Aging Cell2009;8:426-38

[141] GaoX,ReidMA.Serine availability influences mitochondrial dynamics and function through lipid metabolism.Cell Rep2018;22:3507-20 PMCID:PMC6054483

[142] OnoderaR,TanakaN.Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.Sci Rep2014;4:4417 PMCID:PMC3960581

[143] ChanAC.Vitamin E and atherosclerosis.J Nutr1998;128:1593-6

[144] McCartyMF.Ferulic acid may target MyD88-mediated pro-inflammatory signaling - implications for the health protection afforded by whole grains, anthocyanins, and coffee.Med Hypotheses2018;118:114-20

[145] BumrungpertA,TuntipopipatS,KomindrS.Ferulic acid supplementation improves lipid profiles, oxidative stress, and inflammatory status in hyperlipidemic subjects: a randomized, double-blind, placebo-controlled clinical trial.Nutrients2018;10:713 PMCID:PMC6024557

[146] SgarbossaA,diCarlo M.Ferulic acid: a hope for Alzheimer’s disease therapy from plants.Nutrients2015;7:5764-82 PMCID:PMC4517023

[147] Neto-NevesEM,DejaniNN.Ferulic acid and cardiovascular health: therapeutic and preventive potential.Mini Rev Med Chem2021;21:1625-37

[148] NankarR,DobleM.Hybrid drug combination: combination of ferulic acid and metformin as anti-diabetic therapy.Phytomedicine2017;37:10-3

[149] SultanaR.Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders.Biochim Biophys Acta2012;1822:748-52

[150] GuptaA,LokaM,BishayeeA. Chapter eight - ferulic acid-mediated modulation of apoptotic signaling pathways in cancer. In: Advances in protein chemistry and structural biology. 2021. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1876162320300912 [Last accessed on 5 Dec 2023].

[151] TurnerN,GosbyA.Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.Diabetes2008;57:1414-8

[152] CiceroAFG. Berberine and its role in chronic disease. In: Gupta SC, Prasad S, Aggarwal BB, editors. Anti-inflammatory nutraceuticals and chronic diseases. Cham: Springer International Publishing; 2016. pp. 27-45. Available from: http://link.springer.com/10.1007/978-3-319-41334-1_2 [Last accessed on 5 Dec 2023].

[153] KyungS,KimH.α-lipoic acid inhibits IL-8 expression by activating Nrf2 signaling in helicobacter pylori-infected gastric epithelial cells.Nutrients2019;11:2524 PMCID:PMC6835494

[154] PapanasN.Efficacy of α-lipoic acid in diabetic neuropathy.Expert Opin Pharmacother2014;15:2721-31

[155] NovotnyL,CojocelC.alpha-Lipoic acid: the potential for use in cancer therapy.Neoplasma2008;55:81-6

[156] BarutEN,Saygınİ,AriciS.Alpha-lipoic acid: a promising adjuvant for nonsteroidal anti-inflammatory drugs therapy with improved efficacy and gastroprotection.Drug Dev Res2021;82:844-51

[157] TóthF,VécseiL.Natural molecules and neuroprotection: kynurenic acid, pantethine and α-lipoic acid.Int J Mol Sci2021;22:403 PMCID:PMC7795784

[158] KrestininaO,KrestininR,FadeevaI.Astaxanthin prevents mitochondrial impairment induced by isoproterenol in isolated rat heart mitochondria.Antioxidants2020;9:262 PMCID:PMC7139515

[159] LiJ,WuJ.Astaxanthin in liver health and disease: a potential therapeutic agent.Drug Des Devel Ther2020;14:2275-85 PMCID:PMC7293384

[160] KrestininaO,KrestininR.Mitochondrion as a target of astaxanthin therapy in heart failure.Int J Mol Sci2021;22:7964 PMCID:PMC8347622

[161] GiannaccareG,SenniC,ScorciaV.Clinical applications of astaxanthin in the treatment of ocular diseases: emerging insights.Mar Drugs2020;18:239 PMCID:PMC7281326

[162] McCartyMF,DiNicolantonioJJ.Glucosamine for the treatment of osteoarthritis: the time has come for higher-dose trials.J Diet Suppl2019;16:179-92

[163] FengKM,ChenJT.The impact of glucosamine on age-related macular degeneration in patients: a nationwide, population-based cohort study.PLoS ONE2021;16:e0251925 PMCID:PMC8133402

[164] YuL,ChengL.Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1.J Pineal Res2014;57:228-38

[165] FangJ,TengX.Melatonin prevents senescence of canine adipose-derived mesenchymal stem cells through activating NRF2 and inhibiting ER stress.Aging2018;10:2954-72 PMCID:PMC6224246

[166] ChitimusDM,VoiculescuSE.Melatonin’s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease.Biomolecules2020;10:1211 PMCID:PMC7563541

[167] TalibWH,AbuawadA,MahmodAI.Melatonin in cancer treatment: current knowledge and future opportunities.Molecules2021;26:2506 PMCID:PMC8123278

[168] LalanneS,AndersonGM.Melatonin: from pharmacokinetics to clinical use in autism spectrum disorder.Int J Mol Sci2021;22:1490 PMCID:PMC7867370

[169] ChokchaiwongS,LinSH.Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation.Free Radic Res2018;52:1445-55

[170] WangD,XiaM.Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1/miR-378/ATP-binding cassette transporter G1-signaling pathway.Arterioscler Thromb Vasc Biol2014;34:1860-70

[171] MercerJR,FiggN.The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.Free Radic Biol Med2012;52:841-9

[172] XiaoL,ZhangF.The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.Redox Biol2017;11:297-311 PMCID:PMC5196243

[173] MahmoudiK,BourasA.5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas.J Neurooncol2019;141:595-607 PMCID:PMC6538286

[174] PernicovaI.Metformin-mode of action and clinical implications for diabetes and cancer.Nat Rev Endocrinol2014;10:143-56

[175] HattoriY,HattoriS.Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.Hypertension2006;47:1183-8

[176] LaMoiaTE.Cellular and molecular mechanisms of metformin action.Endocr Rev2021;42:77-96 PMCID:PMC7846086

[177] LaFountaine MF,HobsonJC.Fenofibrate therapy to lower serum triglyceride concentrations in persons with spinal cord injury: a preliminary analysis of its safety profile.J Spinal Cord Med2020;43:704-9 PMCID:PMC7534379

[178] PettersenJC,FranconeOL.The PPARα agonists fenofibrate and CP-778875 cause increased β-oxidation, leading to oxidative injury in skeletal and cardiac muscle in the rat.Toxicol Pathol2012;40:435-47

[179] DuncanJG,MedeirosDM,KellyDP.Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-α/PGC-1α gene regulatory pathway.Circulation2007;115:909-17 PMCID:PMC4322937

[180] El-hattabAW,ScagliaF.Mitochondrial DNA maintenance defects.BBA Mol Basis Dis2017;1863:1539-55

[181] DeMarco V,CasadoTC.Therapy of canine hyperlipidemia with bezafibrate.J Vet Intern Med2017;31:717-22 PMCID:PMC5435059

[182] BonnefontJP,LaforêtP.Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.Clin Pharmacol Ther2010;88:101-8

[183] RenB,LiuC.Resveratrol for cancer therapy: challenges and future perspectives.Cancer Lett2021;515:63-72

[184] HuangDD,JiangY,ZhuC.A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications.Biomed Pharmacother2020;125:109767

[185] BreussJM,UhrinP.Resveratrol and its effects on the vascular system.Int J Mol Sci2019;20:1523 PMCID:PMC6479680

[186] KomenJC.Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.Br J Pharmacol2014;171:1818-36 PMCID:PMC3976607

[187] FuCY,YangYT.Sirt1 activator SRT2104 protects against oxygen-glucose deprivation/reoxygenation-induced injury via regulating microglia polarization by modulating Sirt1/NF-κB pathway.Brain Res2021;1753:147236

[188] LibriV,GambarotaG.A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.PLoS One2012;7:e51395 PMCID:PMC3527451

[189] MadhaviYV,YerraVG,NanduriS.Targeting AMPK in diabetes and diabetic complications: energy homeostasis, autophagy and mitochondrial health.Curr Med Chem2019;26:5207-29

[190] DombiE,PoultonJ.Modulating mitophagy in mitochondrial disease.Curr Med Chem2019;25:5597-612

[191] GolubitzkyA,WeissmanS,WikstromJD.Screening for active small molecules in mitochondrial complex I deficient patient’s fibroblasts, reveals AICAR as the most beneficial compound.PLoS One2011;6:e26883 PMCID:PMC3202581

[192] Moreno-UlloaA,Rubio-GayossoI,VillarrealF.Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins.Bioorg Med Chem Lett2013;23:4441-6 PMCID:PMC3741049

[193] KellerA,ElajailiH.(-)-Epicatechin modulates mitochondrial redox in vascular cell models of oxidative stress.Oxid Med Cell Longev2020;2020:6392629 PMCID:PMC7301192

[194] ChenQ,LiJ.Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD).Nutrients2017;9:96 PMCID:PMC5331527

[195] ChunJH,KnaubLA.(-)-Epicatechin improves vasoreactivity and mitochondrial respiration in thermoneutral-housed wistar rat vasculature.Nutrients2022;14:1097 PMCID:PMC8912787

[196] TanabeK,LanaspaMA.Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.Am J Physiol Renal Physiol2012;303:F1264-74 PMCID:PMC5243204

[197] ChenQ,LiangY.Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation.Acta Pharm Sin B2022;12:907-23 PMCID:PMC8897038

[198] RaiPK,LightowlersRN.Potential compounds for the treatment of mitochondrial disease.Br Med Bull2015;116:5-18

[199] SunX,HuB.The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling.Redox Biol2020;28:101309 PMCID:PMC6728880

[200] ZhangL,ZhouCL.RTA-408 protects against propofol-induced cognitive impairment in neonatal mice via the activation of Nrf2 and the inhibition of NF-κB p65 nuclear translocation.Brain Behav2021;11:e01918 PMCID:PMC7821557

[201] RabbaniPS,WaqasB.Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.Diabetes Res Clin Pract2018;139:11-23

[202] SirtoriCR.The pharmacology of statins.Pharmacol Res2014;88:3-11

[203] OesterleA,LiaoJK.Pleiotropic effects of statins on the cardiovascular system.Circ Res2017;120:229-43 PMCID:PMC5467317

[204] BabelovaA,BrandesRP.Anti-atherosclerotic mechanisms of statin therapy.Curr Opin Pharmacol2013;13:260-4

[205] KongF,LinL,HuangW.Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.Biomed Pharmacother2016;82:167-72

[206] ApostolopoulouM,RodenM.The role of mitochondria in statin-induced myopathy.Eur J Clin Invest2015;45:745-54

[207] YangS,LiN.A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy.J Nanobiotechnol2022;20:475 PMCID:PMC9652787

[208] WormaldRPL,SmeethLL. Photodynamic therapy for neovascular age-related macular degeneration. Chichester, UK: John Wiley & Sons, Ltd; 2003. p. CD002030. Available from: https://doi.wiley.com/10.1002/14651858.CD002030 [Last accessed on 5 Dec 2023].

[209] WenX,HamblinMR.Photodynamic therapy in dermatology beyond non-melanoma cancer: an update.Photodiagnosis Photodyn Ther2017;19:140-52 PMCID:PMC5600676

[210] ZhangY,BuY.Real-time imaging mitochondrial viscosity dynamic during mitophagy mediated by photodynamic therapy.Anal Chim Acta2021;1178:338847

[211] AgostinisP,MerlevedeW.Hypericin in cancer treatment: more light on the way.Int J Biochem Cell Biol2002;34:221-41

[212] GalanouMC,TsiourvasD,PaleosCM.Interactive transport, subcellular relocation and enhanced phototoxicity of hypericin encapsulated in guanidinylated liposomes via molecular recognition.Photochem Photobiol2008;84:1073-83

[213] DongX,ZhangZ.Hypericin-mediated photodynamic therapy for the treatment of cancer: a review.J Pharm Pharmacol2021;73:425-36

[214] CourrolLC,MasilamaniV.SARS-CoV-2, hemoglobin and protoporphyrin IX: interactions and perspectives.Photodiagnosis Photodyn Ther2021;34:102324 PMCID:PMC8123386

[215] GammagePA,SimardML.Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.Nat Med2018;24:1691-5 PMCID:PMC6225988

[216] El-HattabAW,AlmannaiM.Therapies for mitochondrial diseases and current clinical trials.Mol Genet Metab2017;122:1-9 PMCID:PMC5773113

[217] WangJ,WongLJC. TK2-related mitochondrial DNA maintenance defect, myopathic form. Seattle: University of Washington; 1993. Available from: http://www.ncbi.nlm.nih.gov/books/NBK114628/ [Last accessed on 5 Dec 2023].

[218] Lopez-GomezC,Sanchez-QuinteroMJ.Deoxycytidine and deoxythymidine treatment for thymidine kinase 2 deficiency.Ann Neurol2017;81:641-52 PMCID:PMC5926768